Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow

David G. Kiely, Robin Condliffe

Source: Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021
Journal Issue: August
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
David G. Kiely, Robin Condliffe. Assessing pulmonary hypertension severity in lung disease is a key step to improving outcomes: embrace resistance and don't be pressurised to go with the flow. Eur Respir J, 58 (2) 2102008; 10.1183/13993003.02008-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Assessing risk in pulmonary arterial hypertension: what we know, what we don't
Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017
Year: 2017



Does the application of an algorithm for non-invasive ventilation in chronic obstructive pulmonary disease improve the initiation process, and patient outcomes?
Source: Annual Congress 2009 - Riding the tiger: noninvasive ventilation and acute respiratory failure
Year: 2009


Optimising pharmacotherapy in patients with pulmonary arterial hypertension and comorbidities, including lung diseases and heart failure: benefits without harm?
Source: International Congress 2018 – Integrated care for patients with pulmonary vascular disease, lung diseases and heart failure
Year: 2018


Image-based recommendations for the evaluation of pulmonary embolism and arterial hypertension: what? when? how?
Source: Virtual Congress 2020 – Image-based guidelines and recommendations in respiratory diseases
Year: 2020


Pathophysiology of pulmonary hypertension: what the interested clinician needs to know
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602345; DOI: 10.1183/13993003.02345-2016
Year: 2017


Impact of pulmonary vascular volume on mortality in IPF: is it time to reconsider the role of vasculature in disease pathogenesis and progression?
Source: Eur Respir J , 49 (2) 1602524; DOI: 10.1183/13993003.02524-2016
Year: 2017


Treatment of pulmonary hypertension due to COPD: can we really hope in better?
Source: Eur Respir J 2005; 26: Suppl. 49, 562s
Year: 2005

Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1802393; 10.1183/13993003.02393-2018
Year: 2019



Pulmonary hypertension associated with left heart disease: efforts to improve the meaning of haemodynamic phenotypes
Source: Eur Respir J, 53 (3) 1801894; 10.1183/13993003.01894-2018
Year: 2019



Does aging affect the outcome of comprehensive pulmonary rehabilitation in patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 426s
Year: 2003

Measuring health in pulmonary hypertension: emphasising the right end-point?
Source: Eur Respir J 2014; 43: 960-962
Year: 2014


The patient tells it! The importance of patient's quality of life perception in pulmonary arterial hypertension risk assessment
Source: Eur Respir J, 57 (2) 2004376; 10.1183/13993003.04376-2020
Year: 2021



Dismantling airway disease with the use of new pulmonary function indices
Source: Eur Respir Rev, 28 (151) 180122; 10.1183/16000617.0122-2018
Year: 2019



Improving adherence in chronic airways disease: are we doing it wrongly?
Source: Breathe, 17 (2) CD000011; 10.1183/20734735.0022-2021
Year: 2021



Low-t3 state a crucial biomarker in determining NIV failure and outcome in pulmonary patient?
Source: Annual Congress 2011 - Mechanical ventilation and weaning
Year: 2011

Does self-management ability improve after pulmonary rehabilitation for chronic obstructive pulmonary disease?
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019


Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet?
Source: Eur Respir Rev 2014; 23: 458-468
Year: 2014



Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Source: Eur Respir Rev 2015; 24: 621-629
Year: 2015